作者: Yu-Bin Ding , Chun-Lan Long , Xue-Qing Liu , Xue-Mei Chen , Liang-Rui Guo
DOI: 10.1371/JOURNAL.PONE.0045364
关键词:
摘要: Background The DNA demethylating agent 5-aza-2′-deoxycytidine (5-aza-CdR) incorporates into and decreases methylation, sparking interest in its use as a potential therapeutic agent. We aimed to determine the effects of maternal 5-aza-CdR treatment on embryo implantation mouse evaluate whether these are associated with decreased levels methyltransferases (Dnmts) three genes (estrogen receptor α [Esr1], progesterone [Pgr], homeobox A10 [Hoxa10]) that vital for control endometrial changes during implantation.